Black Diamond Therapeutics, Inc.
US ˙ NasdaqGS ˙ US09203E1055

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Velleca Mark A.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Velleca Mark A. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:BDTX / Black Diamond Therapeutics, Inc. PRESIDENT & CEO, Director 121.522
US:GTHX / G1 Therapeutics, Inc. Director 116.000
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Velleca Mark A.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb BDTX / Black Diamond Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BDTX / Black Diamond Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BDTX / Black Diamond Therapeutics, Inc. Insider Trades
Insidersalg BDTX / Black Diamond Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BDTX / Black Diamond Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BDTX / Black Diamond Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Velleca Mark A. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-01-31 2025-01-30 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
A - Award 75.000 121.522 161,21
2023-09-18 2023-09-15 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
A - Award 5.208 46.522 12,61 3,60 18.749 167.479
2023-08-10 2023-08-08 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -2.714 116.000 -2,29 2,02 -5.482 234.320
2023-08-10 2023-08-08 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 2.714 118.714 2,34 0,30 814 35.614
2023-08-10 2023-08-08 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -57.286 116.000 -33,06 2,00 -114.492 231.838
2023-08-10 2023-08-08 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 57.286 173.286 49,38 0,39 22.342 67.582
2023-06-16 2023-06-16 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
A - Award 8.929 41.314 27,57 2,10 18.751 86.759
2023-03-20 2023-03-16 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
A - Award 11.228 32.385 53,07 1,67 18.751 54.083
2022-12-19 2022-12-16 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
A - Award 8.424 21.157 66,16 1,50 12.636 31.736
2022-10-20 2022-10-18 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -15.000 116.000 -11,45 11,70 -175.490 1.357.119
2022-10-20 2022-10-18 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 15.000 131.000 12,93 0,39 5.850 51.090
2022-09-22 2022-09-20 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -20.000 116.000 -14,71 13,50 -270.044 1.566.255
2022-09-22 2022-09-20 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 20.000 136.000 17,24 0,39 7.800 53.040
2022-09-19 2022-09-16 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
A - Award 4.294 12.733 50,88 2,62 11.250 33.360
2022-08-18 2022-08-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -80.000 116.000 -40,82 12,64 -1.010.904 1.465.811
2022-08-18 2022-08-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 80.000 196.000 68,97 0,39 31.200 76.440
2022-06-17 2022-06-17 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
A - Award 5.542 8.439 191,30 2,03 11.250 17.131
2022-03-18 2022-03-18 4 BDTX Black Diamond Therapeutics, Inc.
Common Stock
A - Award 2.897 2.897 3,02 8.749 8.749
2022-02-08 2022-02-07 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -15.000 172.286 -8,01
2022-02-08 2022-02-07 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 15.000 116.000 14,85 0,39 5.850 45.240
2021-11-10 2021-11-09 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -40.000 187.286 -17,60
2021-11-10 2021-11-09 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 40.000 101.000 65,57 0,39 15.600 39.390
2021-08-11 2021-08-09 4 BDTX Black Diamond Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 30.000 30.000
2021-07-15 2021-07-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 227.286 -4,21
2021-07-15 2021-07-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 61.000 -14,08 18,49 -184.898 1.127.878
2021-07-15 2021-07-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 71.000 16,39 0,39 3.900 27.690
2021-07-15 2021-07-14 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 237.286 -4,04
2021-07-15 2021-07-14 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 61.000 -14,08 19,08 -190.824 1.164.026
2021-07-15 2021-07-14 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 71.000 16,39 0,39 3.900 27.690
2021-07-15 2021-07-13 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 247.286 -3,89
2021-07-15 2021-07-13 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 61.000 -14,08 19,45 -194.536 1.186.670
2021-07-15 2021-07-13 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 71.000 16,39 0,39 3.900 27.690
2021-06-17 2021-06-17 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 257.286 -3,74
2021-06-17 2021-06-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 61.000 -14,08 21,77 -217.728 1.328.141
2021-06-17 2021-06-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 71.000 16,39 0,39 3.900 27.690
2021-06-17 2021-06-16 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 267.286 -3,61
2021-06-17 2021-06-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 61.000 -14,08 21,74 -217.384 1.326.042
2021-06-17 2021-06-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 71.000 16,39 0,39 3.900 27.690
2021-06-17 2021-06-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 277.286 -3,48
2021-06-17 2021-06-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 61.000 -14,08 22,39 -223.909 1.365.845
2021-06-17 2021-06-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 71.000 16,39 0,39 3.900 27.690
2021-05-25 2021-05-25 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -20.000 287.286 -6,51
2021-05-25 2021-05-25 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 20.000 61.000 48,78 0,39 7.800 23.790
2021-05-13 2021-05-13 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 307.286 -3,15
2021-05-13 2021-05-13 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 41.000 -19,61 20,54 -205.413 842.193
2021-05-13 2021-05-13 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 51.000 24,39 0,39 3.900 19.890
2021-05-13 2021-05-12 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 317.286 -3,06
2021-05-13 2021-05-12 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 41.000 -19,61 20,07 -200.691 822.833
2021-05-13 2021-05-12 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 51.000 24,39 0,39 3.900 19.890
2021-05-13 2021-05-11 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 327.286 -2,96
2021-05-13 2021-05-11 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 41.000 -19,61 19,10 -190.997 783.088
2021-05-13 2021-05-11 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 51.000 24,39 0,39 3.900 19.890
2021-04-15 2021-04-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 337.286 -2,88
2021-04-15 2021-04-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 41.000 -19,61 24,96 -249.631 1.023.487
2021-04-15 2021-04-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 51.000 24,39 0,39 3.900 19.890
2021-04-15 2021-04-14 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 347.286 -2,80
2021-04-15 2021-04-14 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 41.000 -19,61 24,53 -245.272 1.005.615
2021-04-15 2021-04-14 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 51.000 24,39 0,39 3.900 19.890
2021-04-15 2021-04-13 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 357.286 -2,72
2021-04-15 2021-04-13 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 41.000 -19,61 23,89 -238.865 979.346
2021-04-15 2021-04-13 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 51.000 24,39 0,39 3.900 19.890
2021-02-18 2021-02-18 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 28.393 -26,05
2021-02-18 2021-02-18 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 41.000 -19,61 26,02 -260.152 1.066.623
2021-02-18 2021-02-18 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 51.000 24,39 3,72 37.200 189.720
2021-02-18 2021-02-17 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 38.393 -20,66
2021-02-18 2021-02-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -600 41.000 -1,44 28,41 -17.046 1.164.810
2021-02-18 2021-02-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -9.400 41.600 -18,43 27,59 -259.387 1.147.927
2021-02-18 2021-02-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 51.000 24,39 3,72 37.200 189.720
2021-02-18 2021-02-16 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -11.040 48.393 -18,58
2021-02-18 2021-02-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -23 41.000 -0,06 37,00 -851 1.517.000
2021-02-18 2021-02-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -2.700 41.023 -6,18 36,22 -97.780 1.485.648
2021-02-18 2021-02-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -8.317 43.723 -15,98 34,87 -290.021 1.524.660
2021-02-18 2021-02-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 11.040 52.040 26,93 3,72 41.069 193.589
2021-01-21 2021-01-21 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 59.433 -14,40
2021-01-21 2021-01-21 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 41.000 -19,61 20,64 -206.400 846.240
2021-01-21 2021-01-21 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 51.000 24,39 3,72 37.200 189.720
2021-01-21 2021-01-20 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -4.000 367.286 -1,08
2021-01-21 2021-01-20 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 69.433 -12,59
2021-01-21 2021-01-20 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 4.000 41.000 10,81 0,39 1.560 15.990
2021-01-21 2021-01-20 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 37.000 -21,28 21,51 -215.107 795.896
2021-01-21 2021-01-20 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 47.000 27,03 3,72 37.200 174.840
2021-01-21 2021-01-19 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 79.433 -11,18
2021-01-21 2021-01-19 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 37.000 -21,28 20,88 -208.781 772.490
2021-01-21 2021-01-19 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 47.000 27,03 3,72 37.200 174.840
2020-12-17 2020-12-17 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 89.433 -10,06
2020-12-17 2020-12-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 37.000 -21,28 19,97 -199.668 738.772
2020-12-17 2020-12-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 47.000 27,03 3,72 37.200 174.840
2020-12-17 2020-12-16 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 99.433 -9,14
2020-12-17 2020-12-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 37.000 -21,28 19,20 -192.021 710.478
2020-12-17 2020-12-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 47.000 27,03 3,72 37.200 174.840
2020-12-17 2020-12-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 109.433 -8,37
2020-12-17 2020-12-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -10.000 37.000 -21,28 19,43 -194.297 718.899
2020-12-17 2020-12-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 47.000 27,03 3,72 37.200 174.840
2020-03-16 2020-03-13 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -3.000 371.286 -0,80
2020-03-16 2020-03-13 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 3.000 37.000 8,82 0,39 1.170 14.430
2020-02-07 2020-02-06 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
A - Award 220.000 220.000
2020-01-24 2020-01-23 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -6.000 374.286 -1,58
2020-01-24 2020-01-23 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 6.000 34.000 21,43 0,39 2.340 13.260
2019-01-17 2019-01-17 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -9.000 380.286 -2,31
2019-01-17 2019-01-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 9.000 28.000 47,37 0,39 3.510 10.920
2019-01-02 2019-01-02 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
A - Award 225.000 225.000
2018-11-16 2018-11-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -5.000 119.433 -4,02
2018-11-16 2018-11-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -15 19.000 -0,08 40,59 -609 771.210
2018-11-16 2018-11-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -4.985 19.015 -20,77 39,84 -198.602 757.556
2018-11-16 2018-11-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 5.000 24.000 26,32 3,72 18.600 89.280
2018-10-15 2018-10-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -5.000 124.433 -3,86
2018-10-15 2018-10-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -2.837 19.000 -12,99 42,01 -119.177 798.152
2018-10-15 2018-10-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -2.163 21.837 -9,01 40,90 -88.469 893.153
2018-10-15 2018-10-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 5.000 24.000 26,32 3,72 18.600 89.280
2018-10-15 2018-10-11 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 389.286 -2,50
2018-10-15 2018-10-11 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 19.000 111,11 0,39 3.900 7.410
2018-09-19 2018-09-17 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -5.000 129.433 -3,72
2018-09-19 2018-09-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -300 9.000 -3,23 67,95 -20.385 611.550
2018-09-19 2018-09-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -1.865 9.300 -16,70 66,92 -124.798 622.317
2018-09-19 2018-09-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -2.835 11.165 -20,25 65,74 -186.366 733.960
2018-09-19 2018-09-17 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 5.000 14.000 55,56 3,72 18.600 52.080
2018-08-17 2018-08-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -5.000 134.433 -3,59
2018-08-17 2018-08-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -2.301 9.000 -20,36 56,52 -130.046 508.654
2018-08-17 2018-08-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -2.699 11.301 -19,28 55,33 -149.332 625.270
2018-08-17 2018-08-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 5.000 14.000 55,56 3,72 18.600 52.080
2018-07-17 2018-07-16 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -5.000 139.433 -3,46
2018-07-17 2018-07-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -1.200 9.000 -11,76 42,71 -51.255 384.412
2018-07-17 2018-07-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -3.800 10.200 -27,14 41,86 -159.058 426.945
2018-07-17 2018-07-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 5.000 14.000 55,56 3,72 18.600 52.080
2018-07-17 2018-06-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
G - Gift -1.000 9.000 -10,00
2018-05-31 2018-05-31 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise -10.000 399.286 -2,44
2018-05-31 2018-05-31 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise 10.000 10.000 0,39 3.900 3.900
2018-05-16 2018-05-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -7.500 144.433 -4,94
2018-05-16 2018-05-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -1.700 0 -100,00 46,63 -79.277
2018-05-16 2018-05-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -5.800 1.700 -77,33 46,17 -267.787 78.489
2018-05-16 2018-05-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 7.500 7.500 3,72 27.900 27.900
2018-04-17 2018-04-16 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -7.500 151.933 -4,70
2018-04-17 2018-04-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -500 0 -100,00 36,71 -18.355
2018-04-17 2018-04-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -7.000 500 -93,33 35,95 -251.616 17.973
2018-04-17 2018-04-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 7.500 7.500 3,72 27.900 27.900
2018-03-16 2018-03-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -7.500 159.433 -4,49
2018-03-16 2018-03-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -7.500 0 -100,00 38,20 -286.466
2018-03-16 2018-03-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 7.500 7.500 3,72 27.900 27.900
2018-02-16 2018-02-15 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -7.500 166.933 -4,30
2018-02-16 2018-02-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -7.500 0 -100,00 20,00 -150.015
2018-02-16 2018-02-15 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 7.500 7.500 3,72 27.900 27.900
2018-01-17 2018-01-16 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -7.500 174.433 -4,12
2018-01-17 2018-01-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -7.500 0 -100,00 22,99 -172.395
2018-01-17 2018-01-16 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 7.500 7.500 3,72 27.900 27.900
2018-01-04 2018-01-02 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
A - Award 75.000 75.000
2017-12-20 2017-12-18 4 GTHX G1 Therapeutics, Inc.
Stock Options (Right to Buy)
M - Exercise X -7.500 181.933 -3,96
2017-12-20 2017-12-18 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale X -7.500 0 -100,00 20,01 -150.106
2017-12-20 2017-12-18 4 GTHX G1 Therapeutics, Inc.
Common Stock
M - Exercise X 7.500 7.500 3,72 27.900 27.900
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)